Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maja Matic

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Therapeutic Drug Monitoring|March 31, 2016
Genetic Predisposition to Poor Opioid Response in Preterm Infants: Impact of KCNJ6 and COMT Polymorphisms on Pain Relief After Endotracheal IntubationLaure Elens, Elisabeth Norman, Maja Matic, et al.
Clinical Chemistry and Laboratory Medicine|July 18, 2024
Is uracil enough for effective pre-emptive DPD testing?Niels Heersche, Maja Matic, Ron H J Mathijssen, et al.
Pharmacogenomics|November 3, 2017
SLCO1B1 rs4149056 genetic polymorphism predicting methotrexate toxicity in Chinese patients with non-Hodgkin lymphomaLin Yang, Hui Wu, Teun van Gelder, et al.
Pharmacogenomics|January 23, 2020
<i>OPRM1</i> and <i>COMT</i> polymorphisms: implications on postoperative acute, chronic and experimental pain after cardiac surgeryMaja Matic, Sjoerd de Hoogd, Saskia N de Wildt, et al.
Pain|July 18, 2017
ReplyMaja Matic, Gerbrich E van den Bosch, Saskia N de Wildt, et al.
Pain|August 20, 2016
Genetic variants associated with thermal pain sensitivity in a paediatric populationMaja Matic, Gerbrich E van den Bosch, Saskia N de Wildt, et al.
Pharmacogenomics|October 24, 2014
Effect of UGT2B7 -900G>A (-842G>A; rs7438135) on morphine glucuronidation in preterm newborns: results from a pilot cohortMaja Matic, Elisabeth Norman, Anders Rane, et al.
Pharmacogenomics|July 27, 2017
Advanced cancer pain: the search for genetic factors correlated with interindividual variability in opioid requirementMaja Matic, Joost Lm Jongen, Laure Elens, et al.
Genes|October 28, 2023
Implementation of Pharmacogenetics in First-Line Care: Evaluation of Its Use by General PractitionersDenise van der Drift, Mirjam Simoons, Birgit C P Koch, et al.
Pharmacogenomics|July 30, 2016
Opioid treatment failure in cancer patients: the role of clinical and genetic factorsAstrid W Oosten, Maja Matic, Ron H van Schaik, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Therapeutic Drug Monitoring|March 31, 2016
Genetic Predisposition to Poor Opioid Response in Preterm Infants: Impact of KCNJ6 and COMT Polymorphisms on Pain Relief After Endotracheal IntubationLaure Elens, Elisabeth Norman, Maja Matic, et al.
Clinical Chemistry and Laboratory Medicine|July 18, 2024
Is uracil enough for effective pre-emptive DPD testing?Niels Heersche, Maja Matic, Ron H J Mathijssen, et al.
Pharmacogenomics|November 3, 2017
SLCO1B1 rs4149056 genetic polymorphism predicting methotrexate toxicity in Chinese patients with non-Hodgkin lymphomaLin Yang, Hui Wu, Teun van Gelder, et al.
Pharmacogenomics|January 23, 2020
<i>OPRM1</i> and <i>COMT</i> polymorphisms: implications on postoperative acute, chronic and experimental pain after cardiac surgeryMaja Matic, Sjoerd de Hoogd, Saskia N de Wildt, et al.
Pain|July 18, 2017
ReplyMaja Matic, Gerbrich E van den Bosch, Saskia N de Wildt, et al.
Pain|August 20, 2016
Genetic variants associated with thermal pain sensitivity in a paediatric populationMaja Matic, Gerbrich E van den Bosch, Saskia N de Wildt, et al.
Pharmacogenomics|October 24, 2014
Effect of UGT2B7 -900G>A (-842G>A; rs7438135) on morphine glucuronidation in preterm newborns: results from a pilot cohortMaja Matic, Elisabeth Norman, Anders Rane, et al.
Pharmacogenomics|July 27, 2017
Advanced cancer pain: the search for genetic factors correlated with interindividual variability in opioid requirementMaja Matic, Joost Lm Jongen, Laure Elens, et al.
Genes|October 28, 2023
Implementation of Pharmacogenetics in First-Line Care: Evaluation of Its Use by General PractitionersDenise van der Drift, Mirjam Simoons, Birgit C P Koch, et al.
Pharmacogenomics|July 30, 2016
Opioid treatment failure in cancer patients: the role of clinical and genetic factorsAstrid W Oosten, Maja Matic, Ron H van Schaik, et al.
Pageof 4